Evidence map›Paper›PMID 36978355›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Identification of

Elsa De La Cadena, Mateo Mahecha, Ana María Velandia, Juan Carlos García-Betancur, Laura J Rojas, Jessica Porras, Christian Pallares, María Virginia Villegas

Full text read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Molecular characterization ofFrontiers in veterinary science · 2025
    Article
  6. Case Report: Transferable IncX4 plasmid carryingFrontiers in veterinary science · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elsa De La CadenaGrupo de Investigación en Resistencia Antimicrobiana y Epidemiologia Hospitalaria, Universidad El Bosque, Bogotá 110121, Colombia.ORCID 0000-0003-0361-7893
Mateo MahechaGrupo de Investigación REMA, Facultad de Ciencias de la Salud, Programa de Bacteriología y Laboratorio Clínico, Universidad Colegio Mayor de Cundinamarca, Bogotá 110311, Colombia.
Ana María VelandiaGrupo de Investigación REMA, Facultad de Ciencias de la Salud, Programa de Bacteriología y Laboratorio Clínico, Universidad Colegio Mayor de Cundinamarca, Bogotá 110311, Colombia.
Juan Carlos García-BetancurGrupo de Investigación en Resistencia Antimicrobiana y Epidemiologia Hospitalaria, Universidad El Bosque, Bogotá 110121, Colombia.ORCID 0000-0001-5569-6031
Laura J RojasDepartment of Microbiology and Molecular Biology, Case Western Reserve University, Cleveland, OH 44106-7164, USA.
Jessica PorrasGrupo de Investigación en Resistencia Antimicrobiana y Epidemiologia Hospitalaria, Universidad El Bosque, Bogotá 110121, Colombia.ORCID 0000-0002-0352-0146
Christian PallaresGrupo de Investigación en Resistencia Antimicrobiana y Epidemiologia Hospitalaria, Universidad El Bosque, Bogotá 110121, Colombia.
María Virginia VillegasGrupo de Investigación en Resistencia Antimicrobiana y Epidemiologia Hospitalaria, Universidad El Bosque, Bogotá 110121, Colombia.ORCID 0000-0003-1898-9067

Funding

Pfizer SAS MAPP-095939
6 · The paper itself

Abstract

We report the presence of the

Indexed as

colistin resistanceEscherichia colimcr-1

Identifiers

PMID36978355
PMCPMC10044228

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read13
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.